ZA202001108B - Pct and pro-adm as markers for monitoring antibiotic treatment - Google Patents
Pct and pro-adm as markers for monitoring antibiotic treatmentInfo
- Publication number
- ZA202001108B ZA202001108B ZA2020/01108A ZA202001108A ZA202001108B ZA 202001108 B ZA202001108 B ZA 202001108B ZA 2020/01108 A ZA2020/01108 A ZA 2020/01108A ZA 202001108 A ZA202001108 A ZA 202001108A ZA 202001108 B ZA202001108 B ZA 202001108B
- Authority
- ZA
- South Africa
- Prior art keywords
- adm
- markers
- pro
- pct
- antibiotic treatment
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17190913 | 2017-09-13 | ||
| PCT/EP2018/074724 WO2019053117A1 (en) | 2017-09-13 | 2018-09-13 | PCT AND PRO-ADM USED AS CONTROL MARKERS IN ANTIBIOTIC TREATMENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202001108B true ZA202001108B (en) | 2022-08-31 |
Family
ID=59887051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2020/01108A ZA202001108B (en) | 2017-09-13 | 2020-02-21 | Pct and pro-adm as markers for monitoring antibiotic treatment |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20200264199A1 (https=) |
| EP (2) | EP3682241B2 (https=) |
| JP (2) | JP7258860B2 (https=) |
| CN (1) | CN111094981B (https=) |
| BR (1) | BR112020004150A2 (https=) |
| CA (1) | CA3075442C (https=) |
| DK (1) | DK3682241T4 (https=) |
| ES (1) | ES2913298T5 (https=) |
| WO (1) | WO2019053117A1 (https=) |
| ZA (1) | ZA202001108B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111094981B (zh) | 2017-09-13 | 2024-04-16 | B.R.A.H.M.S有限公司 | Pct和pro-adm作为监测抗生素治疗的标记物 |
| RU2724186C1 (ru) * | 2020-01-23 | 2020-06-22 | Наталья Борисовна Гусева | Способ лечения детей раннего возраста с рецидивирующей инфекцией мочевой системы |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2570703B1 (fr) | 1984-09-26 | 1988-07-08 | Commissariat Energie Atomique | Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents |
| US4882733A (en) | 1987-03-13 | 1989-11-21 | Ford Aerospace Corporation | Method and apparatus for combining encoding and modulation |
| FR2664699B1 (fr) | 1990-07-13 | 1995-08-18 | Cis Bio Int | Procede d'amplification du signal d'emission d'un compose luminescent. |
| CN103123359B (zh) * | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
| JP5989965B2 (ja) * | 2008-01-08 | 2016-09-07 | メルク シャープ エンド ドーム リミテッド | ２−｛４−［（３ｓ）−ピペリジン−３−イル］フェニル｝−２ｈ−インダゾール−７−カルボキサミドの薬学的に許容される塩 |
| EP2438447B1 (en) | 2009-06-05 | 2015-02-18 | B.R.A.H.M.S GmbH | Detection of bacterial infections in subjects suffering from dyspnea. |
| EP2545379B1 (en) * | 2010-03-08 | 2015-09-30 | B.R.A.H.M.S GmbH | Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints |
| WO2012059477A1 (en) * | 2010-11-01 | 2012-05-10 | B.R.A.H.M.S Gmbh | Prognosis and risk assessment of patients with non-specific complaints |
| US11067586B2 (en) * | 2011-11-16 | 2021-07-20 | Sphingotec Gmbh | Adrenomedullin assays and methods for determining mature adrenomedullin |
| EP2637023A1 (en) * | 2012-03-08 | 2013-09-11 | B.R.A.H.M.S GmbH | Prediction of outcome in patients with chronic obstructive pulmonary disease |
| EP2976646B1 (en) * | 2013-03-20 | 2020-08-19 | sphingotec GmbH | Adrenomedullin to guide therapy of blood pressure decline |
| CN111094981B (zh) | 2017-09-13 | 2024-04-16 | B.R.A.H.M.S有限公司 | Pct和pro-adm作为监测抗生素治疗的标记物 |
-
2018
- 2018-09-13 CN CN201880059114.XA patent/CN111094981B/zh active Active
- 2018-09-13 WO PCT/EP2018/074724 patent/WO2019053117A1/en not_active Ceased
- 2018-09-13 DK DK18765658.2T patent/DK3682241T4/da active
- 2018-09-13 EP EP18765658.2A patent/EP3682241B2/en active Active
- 2018-09-13 CA CA3075442A patent/CA3075442C/en active Active
- 2018-09-13 JP JP2020515656A patent/JP7258860B2/ja active Active
- 2018-09-13 EP EP22159272.8A patent/EP4027145A1/en active Pending
- 2018-09-13 US US16/646,799 patent/US20200264199A1/en active Pending
- 2018-09-13 BR BR112020004150-5A patent/BR112020004150A2/pt unknown
- 2018-09-13 ES ES18765658T patent/ES2913298T5/es active Active
-
2020
- 2020-02-21 ZA ZA2020/01108A patent/ZA202001108B/en unknown
-
2023
- 2023-04-05 JP JP2023061326A patent/JP2023095851A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN111094981B (zh) | 2024-04-16 |
| CA3075442C (en) | 2024-04-02 |
| EP3682241A1 (en) | 2020-07-22 |
| EP4027145A1 (en) | 2022-07-13 |
| RU2020111718A3 (https=) | 2022-02-01 |
| WO2019053117A1 (en) | 2019-03-21 |
| RU2020111718A (ru) | 2021-10-13 |
| EP3682241B2 (en) | 2025-09-10 |
| US20200264199A1 (en) | 2020-08-20 |
| JP7258860B2 (ja) | 2023-04-17 |
| DK3682241T4 (da) | 2025-10-06 |
| JP2020533603A (ja) | 2020-11-19 |
| DK3682241T3 (da) | 2022-05-16 |
| ES2913298T3 (es) | 2022-06-01 |
| CN111094981A (zh) | 2020-05-01 |
| CA3075442A1 (en) | 2019-03-21 |
| EP3682241B1 (en) | 2022-03-30 |
| WO2019053117A8 (en) | 2021-01-21 |
| BR112020004150A2 (pt) | 2020-09-08 |
| ES2913298T5 (en) | 2026-01-02 |
| JP2023095851A (ja) | 2023-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL247211A0 (en) | Systems and methods for tissue healing | |
| EP3285682A4 (en) | Intra-oral light-therapy apparatuses and methods for their use | |
| EP3164080A4 (en) | Methods and devices for surgical access | |
| EP3119188A4 (en) | System and method for treating livestock | |
| EP3222239A4 (en) | Treatment tool and treatment system | |
| GB2567616B (en) | Treatment method | |
| GB2571601B (en) | Treatment method | |
| DK3630111T3 (en) | Compounds and methods for treating bacterial infections | |
| SG11202001806TA (en) | Treatment method | |
| CA3249464A1 (en) | Antisense antibacterial compounds and methods | |
| PL3393415T3 (pl) | Bandaż | |
| EP3182915A4 (en) | Bone treatment systems and methods | |
| EP3130304A4 (en) | Treatment tool and surgical system | |
| PL3468374T3 (pl) | Zaawansowany sposób utleniania i system do redukcji drobnoustrojów | |
| SG11202003216QA (en) | Methods for monitoring vedolizumab treatment | |
| EP3325028A4 (en) | METHODS AND SYSTEMS FOR TREATING ENDOMETRIOSIS | |
| ZA202001108B (en) | Pct and pro-adm as markers for monitoring antibiotic treatment | |
| EP3137129A4 (en) | Systems and methods for tissue treatment | |
| GB201402909D0 (en) | Treating infection | |
| HUE052429T2 (hu) | Összeállítás sebészeti kezeléshez | |
| EP3269369A4 (en) | Respiratory infection treating agent | |
| SG11202004923XA (en) | Sterilization method | |
| GB201718985D0 (en) | Treatment | |
| GB201708413D0 (en) | Incubator and method for use | |
| GB2558090B (en) | Prevention and treatment for microbial infections |